Precision Tools in Immuno-Oncology: Synthetic Gene Circuits for Cancer Immunotherapy

被引：5

作者：

Bonfa, Giuliano ^{[1
]}

Blazquez-Roman, Juan ^{[1
]}

Tarnai, Rita ^{[1
]}

Siciliano, Velia ^{[1
]}

机构：

[1] Ist Italiano Tecnol IIT, Synthet & Syst Biol Lab Biomed, I-80125 Naples, Italy

来源：

VACCINES | 2020年 / 8卷 / 04期

关键词：

synthetic biology; synthetic immunology; cell-based therapies; T-cell engineering; T-cell immunotherapies; Boolean logic in T cells; CAR-T-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; ADOPTIVE IMMUNOTHERAPY; EFFECTOR FUNCTION; SAFETY SWITCH; SUICIDE GENE; THERAPY; CYTOKINE; EFFICACY; RESPONSES;

D O I：

10.3390/vaccines8040732

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Engineered mammalian cells for medical purposes are becoming a clinically relevant reality thanks to advances in synthetic biology that allow enhanced reliability and safety of cell-based therapies. However, their application is still hampered by challenges including time-consuming design-and-test cycle iterations and costs. For example, in the field of cancer immunotherapy, CAR-T cells targeting CD19 have already been clinically approved to treat several types of leukemia, but their use in the context of solid tumors is still quite inefficient, with additional issues related to the adequate quality control for clinical use. These limitations can be overtaken by innovative bioengineering approaches currently in development. Here we present an overview of recent synthetic biology strategies for mammalian cell therapies, with a special focus on the genetic engineering improvements on CAR-T cells, discussing scenarios for the next generation of genetic circuits for cancer immunotherapy.

引用

页码：1 / 17

页数：18

共 114 条

[61] c-Jun overexpression in CAR T cells induces exhaustion resistance [J].

Lynn, Rachel C. ;

Weber, Evan W. ;

Sotillo, Elena ;

Gennert, David ;

Xu, Peng ;

Good, Zinaida ;

Anbunathan, Hima ;

Lattin, John ;

Jones, Robert ;

Tieu, Victor ;

Nagaraja, Surya ;

Granja, Jeffrey ;

de Bourcy, Charles F. A. ;

Majzner, Robbie ;

Satpathy, Ansuman T. ;

Quake, Stephen R. ;

Monje, Michelle ;

Chang, Howard Y. ;

Mackall, Crystal L. .

NATURE, 2019, 576 (7786) :293-+

[62] Versatile strategy for controlling the specificity and activity of engineered T cells [J].

Ma, Jennifer S. Y. ;

Kim, Ji Young ;

Kazane, Stephanie A. ;

Choi, Sei-hyun ;

Yun, Hwa Young ;

Kim, Min Soo ;

Rodgers, David T. ;

Pugh, Holly M. ;

Singer, Oded ;

Sun, Sophie B. ;

Fonslow, Bryan R. ;

Kochenderfer, James N. ;

Wright, Timothy M. ;

Schultz, Peter G. ;

Young, Travis S. ;

Kim, Chan Hyuk ;

Cao, Yu .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (04) :E450-E458

[63] Interleukin-23 engineering improves CAR T cell function in solid tumors [J].

Ma, Xingcong ;

Shou, Peishun ;

Smith, Christof ;

Chen, Yuhui ;

Du, Hongwei ;

Sun, Chuang ;

Kren, Nancy Porterfield ;

Michaud, Daniel ;

Ahn, Sarah ;

Vincent, Benjamin ;

Savoldo, Barbara ;

Pylayeva-Gupta, Yuliya ;

Zhang, Shuqun ;

Dotti, Gianpietro ;

Xu, Yang .

NATURE BIOTECHNOLOGY, 2020, 38 (04) :448-+

[64]

MacDonald JT, 2017, METHODS MOL BIOL, V1651, P249, DOI 10.1007/978-1-4939-7223-4_18

[65] Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies [J].

Mamonkin, Maksim ;

Mukherjee, Malini ;

Srinivasan, Madhuwanti ;

Sharma, Sandhya ;

Gomes-Silva, Diogo ;

Mo, Feiyan ;

Krenciute, Giedre ;

Orange, Jordan S. ;

Brenner, Malcolm K. .

CANCER IMMUNOLOGY RESEARCH, 2018, 6 (01) :47-58

[66] T Cells Expressing Chimeric Antigen Receptors Can Cause Anaphylaxis in Humans [J].

Maus, Marcela V. ;

Haas, Andrew R. ;

Beatty, Gregory L. ;

Albelda, Steven M. ;

Levine, Bruce L. ;

Liu, Xiaojun ;

Zhao, Yangbing ;

Kalos, Michael ;

June, Carl H. .

CANCER IMMUNOLOGY RESEARCH, 2013, 1 (01) :26-31

[67] Advances in Cancer Immunotherapy in Solid Tumors [J].

Menon, Smitha ;

Shin, Sarah ;

Dy, Grace .

CANCERS, 2016, 8 (12)

[68] Synthetic RNA-Based Immunomodulatory Gene Circuits for Cancer Immunotherapy [J].

Nissim, Lior ;

Wu, Ming-Ru ;

Pery, Erez ;

Binder-Nissim, Adina ;

Suzuki, Hiroshi I. ;

Stupp, Doron ;

Wehrspaun, Claudia ;

Tabach, Yuval ;

Sharp, Phillip A. ;

Lu, Timothy K. .

CELL, 2017, 171 (05) :1138-+

[69] Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance [J].

Palmer, Douglas C. ;

Guittard, Geoffrey C. ;

Franco, Zulmarie ;

Crompton, Joseph G. ;

Eil, Robert L. ;

Patel, Shashank J. ;

Ji, Yun ;

Van Panhuys, Nicholas ;

Klebanoff, Christopher A. ;

Sukumar, Madhusudhanan ;

Clever, David ;

Chichura, Anna ;

Roychoudhuri, Rahul ;

Varma, Rajat ;

Wang, Ena ;

Gattinoni, Luca ;

Marincola, Francesco M. ;

Balagopalan, Lakshmi ;

Samelson, Lawrence E. ;

Restifo, Nicholas P. .

JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (12) :2095-2113

[70] Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists [J].

Peggs, K. S. ;

Quezada, S. A. ;

Allison, J. P. .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2009, 157 (01) :9-19

← 2 3 4 5 6 7 8 9 10 11 →